Jahrgang 1 (2017), Ausgabe 1
Complete issue
Editorial
Editorial
Seite 1 - 2
Articles
Reports
Austria ∙ Further Cuts in the Reimbursement of Medicinal Products
Seite 22 - 25
Belgium ∙ 'Sunshine' in Belgium: New Statutory Transparency Requirements for Life Sciences Companies
Seite 26 - 30
Denmark ∙ Latest Developments in Danish Healthcare Professional Transparency Regulation
Seite 31 - 36
Germany ∙ The Albiglutide Controversy: A Paradigm Shift in Pricing Negotiations?
Seite 37 - 41
Case Notes
The Court as Pontius Pilate: Reflecting on Missed Opportunities in the PIP Decision open-access
Seite 42 - 48
Jurisdiction
Jurisdiction
Seite 49 - 51
Legislation
New EU Pharmaceutical Law and Policy
Seite 52 - 53